Gratifii Limited (ASX:GTI) has reported a change in director shareholdings following a shareholder-sanctioned capital raise. On 21 July 2026, director Patrina Kerr purchased 625,000 fully paid ordinary shares at $0.04 each and received 312,500 unlisted options through a placement, investing a total of $25,000. This transaction was authorized by shareholders at an Extraordinary General Meeting on 13 July 2026 and executed during a closed period with prior ASX approval. Kerr’s direct shareholding now totals 3.48 million shares, underscoring ongoing director confidence in Gratifii’s prospects.
Key Points
- Gratifii Limited (GTI) disclosed a director interest change under ASX Listing Rule 3.19A.2.
- Director Patrina Kerr acquired 625,000 shares at $0.04 each plus 312,500 free-attaching unlisted options exercisable at $0.10 until 20 July 2028.
- Total cash consideration was $25,000; options were issued at no cost on a 1-for-2 basis.
- Shareholder approval was granted at the 13 July 2026 Extraordinary General Meeting under Listing Rule 10.11, Resolution 6.
- Post-acquisition, Kerr’s direct holding increased to 3.48 million shares, with an additional 4 million shares held indirectly via Bombora Capital Limited as trustee for PHACT Investment Trust.
Director Patrina Kerr Expands Direct Shareholding via Placement
Patrina Kerr, director of Gratifii Limited, enhanced her direct equity stake by participating in the company’s recent placement. Before the 21 July 2026 transaction, Kerr held 2.85 million fully paid ordinary shares, 214,008 unlisted performance rights, and 1.02 million loan funded shares directly. The acquisition of 625,000 shares represents a significant addition to her direct holdings and reflects active board engagement in the capital raise.
Following settlement, Kerr’s direct shareholding rose to 3.48 million fully paid ordinary shares. Additionally, she received 312,500 unlisted options exercisable at $0.10 each, expiring on 20 July 2028. Her existing holdings of 214,008 performance rights and 1.02 million loan funded shares remain unchanged. This comprehensive equity position highlights Kerr’s sustained investment commitment alongside her incentive-based holdings.
Shareholder Approval Secured at Extraordinary General Meeting
The share placement was conducted under shareholder approval obtained at the Extraordinary General Meeting on 13 July 2026. The transaction was authorized as Resolution 6 pursuant to ASX Listing Rule 10.11, which regulates related party transactions and director involvement in capital raisings. This process ensures transparency and protects shareholder interests by providing oversight of director acquisitions during capital raises.
The eight-day gap between shareholder approval and settlement on 21 July 2026 aligns with standard timelines for implementing authorized placements. The approval process confirmed that the $0.04 per share price and the 1-for-2 free option entitlement were subject to shareholder scrutiny prior to execution, reinforcing governance standards and equitable treatment of investors.
Placement Pricing, Option Details, and Total Consideration
The placement shares were priced at $0.04 each, with Kerr acquiring 625,000 shares for a total cash outlay of $25,000. This price matched the terms offered to all participants in the capital raise. Alongside the shares, Kerr received 312,500 unlisted options free of charge at a ratio of one option per two shares subscribed.
The unlisted options carry an exercise price of $0.10 and expire on 20 July 2028, offering a two-year exercise period. Issued at nil cost, these options serve as an incentive aligning shareholder interests with future share price appreciation. The $0.10 exercise price represents a 150% premium over the placement price, reflecting the options’ time value and conditional exercise rights.
Indirect Holdings via Bombora Capital Limited and PHACT Investment Trust
Beyond her direct holdings, Patrina Kerr holds an indirect interest in 4 million fully paid ordinary shares through Bombora Capital Limited as trustee for the PHACT Investment Trust. Kerr serves as both director and shareholder of Bombora Capital Limited and is a beneficiary of the PHACT Investment Trust. This structure is commonly used to manage director investments and provide flexibility through corporate and trust arrangements.
This indirect holding was unaffected by the 21 July 2026 placement and is reported separately from Kerr’s direct shareholding. Combined, Kerr’s direct and indirect stakes amount to approximately 7.48 million shares, excluding performance rights and loan funded shares. Such arrangements facilitate separation of investment management from board responsibilities and support estate planning objectives.
Retention of Loan Funded Shares and Performance Rights
In addition to ordinary shares and new options, Kerr retains 1.02 million loan funded shares and 214,008 unlisted performance rights directly. These instruments were not impacted by the recent placement and remain integral to her overall equity position. Loan funded shares typically arise from employee share schemes or incentive plans and may be subject to holding restrictions or conditions.
Performance rights represent conditional equity convertible into shares upon meeting specified performance criteria. Kerr’s diversified holdings—comprising outright shares, performance rights, and loan funded shares—reflect a layered equity structure designed to align management incentives with shareholder value creation over defined performance periods.
Closed Period Transaction with Prior ASX Clearance
Kerr’s acquisition occurred during an ASX-defined closed period, which restricts director trading around sensitive times such as financial announcements or when material non-public information is held. Despite this, the transaction proceeded after obtaining prior written clearance from the ASX on 21 July 2026, the settlement date. This approval permits authorized directors to complete pre-approved trades during closed periods.
Prior ASX clearance ensures director transactions during closed periods are transparent and free from potential insider advantage. The clearance granted on the transaction date indicates the placement was part of a pre-planned capital raise with appropriate disclosure and governance controls, maintaining market integrity while allowing legitimate director participation.
Gratifii Limited’s Corporate Profile and Equity Composition
Gratifii Limited (ABN 47 125 688 940) is an ASX-listed entity operating across various market segments. While the update does not detail current operations, the company’s equity comprises ordinary shares, unlisted options, loan funded shares, and performance rights, illustrating a diversified capital and incentive structure. The shareholder-approved placement and director participation highlight an active approach to capital management and equity funding.
The issuance of 625,000 shares to Kerr, alongside the broader capital raise framework, suggests Gratifii is pursuing strategic equity financing or refinancing. The $0.04 share price and free attaching options reflect prevailing market conditions and investor incentives. Director involvement often signals board confidence in the company’s strategic direction and financial outlook.
Governance Significance of Director Share Acquisition
Director participation in capital raises, subject to shareholder approval under Listing Rule 10.11, is a key governance mechanism for ASX-listed companies. Kerr’s acquisition authorized at the 13 July 2026 EGM demonstrates adherence to regulatory protocols ensuring transparency and fairness in related party transactions.
Disclosure of transaction details through the Appendix 3Y filing, including acquisition date, pricing, option terms, and shareholdings before and after the transaction, satisfies continuous disclosure obligations under the Corporations Act. This transparency enables investors and market participants to monitor insider trading and reinforces confidence that director share acquisitions occur on equitable terms.
Capital Raise Context and Broader Fundraising Implications
The shareholder resolution passed at the 13 July 2026 EGM indicates Gratifii’s capital raise involved multiple participants beyond director accommodation. The placement terms—625,000 shares at $0.04 each with 1-for-2 free attaching options—applied uniformly to all eligible investors. Kerr’s $25,000 investment suggests the total capital raised was substantially larger, involving multiple participants under identical terms.
Although the company has not disclosed the overall capital raised, participant identities, or use of proceeds, the EGM approval and placement structure imply a material fundraising relative to the existing equity base. Kerr’s participation and shareholder endorsement position the capital raise as a strategic initiative likely aimed at supporting operations, acquisitions, debt reduction, or other corporate objectives aligned with Gratifii’s growth plans.